TY - JOUR
T1 - Shared decision making in cancer treatment
T2 - A Dutch national survey on patients' preferences and perceptions
AU - Kuijpers, Marieke M.T.
AU - van Veenendaal, Haske
AU - Engelen, Vivian
AU - Visserman, Ella
AU - Noteboom, Eveline A.
AU - Stiggelbout, Anne M.
AU - May, Anne M.
AU - de Wit, Niek
AU - van der Wall, Elsken
AU - Helsper, Charles W.
N1 - Funding Information:
An unrestricted educational grant was provided by Danone Ecosystem Funds and in‐kind support was provided by the NFK to use their online questionnaire tool (“Doneer‐je‐ervaring”) for approaching cancer patients for the study and gather the data from respondents.
Publisher Copyright:
© 2021 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd.
PY - 2022/1
Y1 - 2022/1
N2 - Objective: Shared decision making (SDM) for cancer treatment yields positive results. However, it appears that discussing essential topics for SDM is not fully integrated into treatment decision making yet. Therefore, we aim to explore to what extent discussion of therapy options, treatment consequences, and personal priorities is preferred and perceived by (former) cancer patients. Methods: An online questionnaire was distributed by the Dutch Federation of Cancer Patient Organisations among (former) cancer patients in 2018. Results: Among 3785 (former) cancer patients, 3254 patients (86%) had discussed treatments with their health care provider (HCP) and were included for analysis. Mean age was 62.1 ± 11.5; 55% were female. Discussing the option to choose no (further) treatment was rated by 2751 (84.5%) as very important (median score 9/10—IQR 8–10). Its occurrence was perceived by 28% (N = 899), and short- and long-term treatment consequences were discussed in 81% (N = 2626) and 53% (N = 1727), respectively. An unmet wish to discuss short- and long-term consequences was reported by 22% and 26%, respectively. Less than half of the (former) cancer patients perceived that personal priorities (44%) and future plans (34%) were discussed. Conclusion: In the perception of (former) cancer patients, several essential elements for effective SDM are insufficiently discussed during cancer treatment decision making.
AB - Objective: Shared decision making (SDM) for cancer treatment yields positive results. However, it appears that discussing essential topics for SDM is not fully integrated into treatment decision making yet. Therefore, we aim to explore to what extent discussion of therapy options, treatment consequences, and personal priorities is preferred and perceived by (former) cancer patients. Methods: An online questionnaire was distributed by the Dutch Federation of Cancer Patient Organisations among (former) cancer patients in 2018. Results: Among 3785 (former) cancer patients, 3254 patients (86%) had discussed treatments with their health care provider (HCP) and were included for analysis. Mean age was 62.1 ± 11.5; 55% were female. Discussing the option to choose no (further) treatment was rated by 2751 (84.5%) as very important (median score 9/10—IQR 8–10). Its occurrence was perceived by 28% (N = 899), and short- and long-term treatment consequences were discussed in 81% (N = 2626) and 53% (N = 1727), respectively. An unmet wish to discuss short- and long-term consequences was reported by 22% and 26%, respectively. Less than half of the (former) cancer patients perceived that personal priorities (44%) and future plans (34%) were discussed. Conclusion: In the perception of (former) cancer patients, several essential elements for effective SDM are insufficiently discussed during cancer treatment decision making.
KW - communication
KW - neoplasms
KW - patient preference
KW - perception
KW - shared decision making
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85118387440&partnerID=8YFLogxK
U2 - 10.1111/ecc.13534
DO - 10.1111/ecc.13534
M3 - Article
C2 - 34729832
SN - 1365-2354
VL - 31
JO - European Journal of Cancer Care
JF - European Journal of Cancer Care
IS - 1
M1 - e13534
ER -